![John Butler](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Butler
Directeur Général chez
AKEBIA THERAPEUTICS, INC.
Fortune : 2 M $ au 31/05/2026
Profil
John P.
Butler is President, Chief Executive Officer & Director at Akebia Therapeutics, Inc. since 2024.
He is Director at Wavebreak Therapeutics Ltd. since 2023.
He is a Member of the Health Section Governing Board at Biotechnology Innovation Organization since 2024.
Former roles include Chief Executive Officer at Inspiration Biopharmaceuticals, Inc. in 2011; Chairman at Keryx Biopharmaceuticals, Inc. from 2016 to 2017; Chairman at American Kidney Fund, Inc. from 2013 to 2015; Chairman at Kidney Care Partners from 2020 to 2024; Independent Director at Harmony Biosciences Management, Inc. from 2018 to 2023; Independent Director at Relypsa, Inc. from 2013 to 2016; Product Manager at Amgen, Inc. from 1995 to 1997; SVP & President-Cardiometabolic & Renal at Genzyme Corp.
from 2009 to 2011; and Head of Sales & Marketing at Hoffmann-La Roche, Inc. Education includes undergraduate studies at Manhattan University and an MBA from Baruch College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 2 206 149 ( 0,82 % ) | 2 M $ | 31/05/2026 |
Postes actifs de John Butler
| Sociétés | Poste | Début |
|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Directeur Général | 16/09/2013 |
Wavebreak Therapeutics Ltd.
 Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops small molecule therapeutics for multiple protein misfolding diseases | Directeur/Membre du Conseil | 01/01/2023 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Corporate Officer/Principal | 01/01/2024 |
Anciens postes connus de John Butler
| Sociétés | Poste | Fin |
|---|---|---|
Kidney Care Partners
 Kidney Care Partners Medical/Nursing ServicesHealth Services Operates as nephrologists | Président | 01/01/2024 |
| ZYNERBA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 10/10/2023 |
| KERYX BIOPHARMACEUTICALS | Président | 01/01/2017 |
| RELYPSA INC | Directeur/Membre du Conseil | 01/09/2016 |
American Kidney Fund, Inc.
 American Kidney Fund, Inc. Medical/Nursing ServicesHealth Services Provides treatment & financial assistance to kidney patients | Président | 01/01/2015 |
Formation de John Butler
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
82
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Zynerba Pharmaceuticals, Inc.
 Zynerba Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Delivers dermal solutions for the treatment of neuroscience disorders | Health Technology |
Inspiration Biopharmaceuticals, Inc.
 Inspiration Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Produces intravenous recombinant therapies and develops non-invasive applications | Health Technology |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
Manhattan College
 Manhattan College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baruch College
 Baruch College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akebia Therapeutics, Inc.
 Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
Kidney Care Partners
Kidney Care Partners Medical/Nursing ServicesHealth Services Operates as nephrologists | Health Services |
Relypsa, Inc.
 Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops non-absorbed polymeric drugs for applications in cardiovascular and renal diseases | Health Technology |
American Kidney Fund, Inc.
American Kidney Fund, Inc. Medical/Nursing ServicesHealth Services Provides treatment & financial assistance to kidney patients | Health Services |
Wavebreak Therapeutics Ltd.
Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops small molecule therapeutics for multiple protein misfolding diseases | Health Technology |
Choisissez Zonebourse 
